LAMA2 and epilepsy: Seizures occurred in 9.5% (11/116) of LAMA2-CMD patients (night with epilepsy and two with febrile seizures) and 35.7% (5/14) of LGMDR23 patients (three with epilepsy and two with febrile seizures).